127 related articles for article (PubMed ID: 12493962)
1. The incidental discovery of follicular thyroid cancer with in-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lung.
Villa G; Ratto GB; Carletto M; Rouhanifar H; Piccardo A; Tommasi L; Altrinetti V; Mereu C; Mariani G
Clin Nucl Med; 2003 Jan; 28(1):45-6. PubMed ID: 12493962
[No Abstract] [Full Text] [Related]
2. Somatostatin-receptor scintigraphy of subcutaneous and thyroid metastases from bronchial carcinoid.
Krausz Y; Pfeffer MR; Glaser B; Lafair J
J Nucl Med; 1996 Sep; 37(9):1537-9. PubMed ID: 8790214
[TBL] [Abstract][Full Text] [Related]
3. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
[TBL] [Abstract][Full Text] [Related]
4. [Somatostatin receptor status in non-medullary thyroid carcinoma].
Görges R; Kahaly G; Müller-Brand J; Mäcke H; Walgenbach S; Bruns C; Andreas J; Brandt-Mainz K; Bockisch A
Nuklearmedizin; 1999; 38(1):15-23. PubMed ID: 9987777
[TBL] [Abstract][Full Text] [Related]
5. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor.
Rufini V; Salvatori M; Saletnich I; Valenza V; Maussier ML; Martino G; Corsello SM; Pantusa M; Casolo A; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):140-4. PubMed ID: 9002774
[TBL] [Abstract][Full Text] [Related]
7. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of a lung mass with a somatostatin analog scan.
Tovar EA
Ann Thorac Surg; 2000 Mar; 69(3):954. PubMed ID: 10750801
[No Abstract] [Full Text] [Related]
9. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
[TBL] [Abstract][Full Text] [Related]
10. Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy.
Reincke M; Allolio B; Arlt W; Körber C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3399-400; author reply 3402-3. PubMed ID: 10487718
[No Abstract] [Full Text] [Related]
11. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
13. [Lung accumulation of 99mTc-pertechnetate in thyroid scintigraphy].
Gil Martínez E; Calvo Morón MC; Ruiz Franco-Baux JV; Cambil Molina T; Castro Montaño J
Rev Esp Med Nucl; 2002; 21(6):435-6. PubMed ID: 12425892
[No Abstract] [Full Text] [Related]
14. Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.
Kolesnikov-Gauthier H; Huglo D; Nocaudie M; Marchandise X
J Nucl Med; 1999 Jan; 40(1):33-9. PubMed ID: 9935053
[TBL] [Abstract][Full Text] [Related]
15. A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions.
Minutoli F; Herberg A; Sindoni A; Cardile D; Cucinotta M; Baldari S
J Endocrinol Invest; 2012 Jul; 35(7):708-9. PubMed ID: 22932274
[No Abstract] [Full Text] [Related]
16. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
17. Follow-up of a carcinoid tumor in the middle ear by in-111 pentetreotide scintigraphy.
Martínez-Lázaro R; Cortes-Blanco A; Moreno-Selva A; Morote MB
Clin Nucl Med; 2007 Jun; 32(6):466-7. PubMed ID: 17515757
[No Abstract] [Full Text] [Related]
18. Imaging of bronchial carcinoid tumours with indium-111 pentetreotide.
O'Byrne KJ; O'Hare NJ; Freyne PJ; Luke DA; Clancy LJ; Prichard JS; Carney DN
Thorax; 1994 Mar; 49(3):284-6. PubMed ID: 7911261
[TBL] [Abstract][Full Text] [Related]
19. An 111In-Pentetreotide Positive Sclerosing Pneumocytoma.
Savelli G; Bnà C; Zambelli C; Illuminati S; Bonello L
Clin Nucl Med; 2017 Apr; 42(4):282-284. PubMed ID: 28166143
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]